Company Filing History:
Years Active: 2016
Title: Katherine Schouest: Innovator in Nucleic Acid Hybridization and HIV Detection
Introduction
Katherine Schouest is a prominent inventor based in Cary, NC (US). She has made significant contributions to the fields of nucleic acid hybridization and human immunodeficiency virus (HIV) detection. With a total of 2 patents, her work has advanced the methodologies used in molecular diagnostics.
Latest Patents
Katherine's latest patents include innovative compositions, methods, and kits for nucleic acid hybridization. One of her notable inventions involves polynucleotides that have a first segment contiguous with a second segment. The first segment's sequence is complementary to a probe segment for detecting target nucleic acid sequences. This invention allows for the use of dual-labeled probes (DLPs) in assays aimed at detecting these sequences. Additionally, she has developed methods, compositions, and kits for determining the presence of HIV in samples. This invention focuses on the simultaneous detection of HIV-1 group M, HIV-1 group O, and HIV-2.
Career Highlights
Katherine Schouest is currently employed at Grifols Therapeutics Inc., where she continues to innovate in her field. Her work has been instrumental in enhancing diagnostic techniques that are crucial for public health.
Collaborations
Katherine has collaborated with notable coworkers, including Danuta Wronska and Leslie Tremlett. These partnerships have contributed to the success of her inventions and the advancement of research in her areas of expertise.
Conclusion
Katherine Schouest's contributions to nucleic acid hybridization and HIV detection exemplify her dedication to innovation in the biomedical field. Her patents reflect her commitment to improving diagnostic methods that can have a significant impact on healthcare.